IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.64M | -9.71M | -9.76M | -10.68M | -8.33M |
| Total Depreciation and Amortization | 272.60K | 376.10K | 473.20K | 1.81M | 1.31M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -659.70K | -468.00K | -1.84M | -4.95M | -9.23M |
| Change in Net Operating Assets | -888.60K | 2.98M | 2.58M | 3.73M | 6.45M |
| Cash from Operations | -9.91M | -6.82M | -8.55M | -10.09M | -9.81M |
| Capital Expenditure | -44.00K | -44.00K | -44.00K | -- | -30.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -78.00K | -78.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.60K | -31.10K | 19.40K | 102.40K | 91.40K |
| Cash from Investing | -73.60K | -75.10K | -24.60K | 24.40K | -16.60K |
| Total Debt Issued | -- | -- | 19.76M | 19.76M | 19.76M |
| Total Debt Repaid | -22.13M | -20.16M | -21.14M | -21.22M | -21.71M |
| Issuance of Common Stock | 103.17M | 42.75M | 38.43M | 41.29M | 40.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00K | 17.00K | -422.00K | -421.00K | -421.00K |
| Cash from Financing | 11.90M | 5.96M | 7.18M | 9.96M | 8.63M |
| Foreign Exchange rate Adjustments | -27.90K | -6.80K | 2.30K | -5.70K | 32.30K |
| Miscellaneous Cash Flow Adjustments | 1.00K | 1.00K | 900.00 | -3.10K | -2.10K |
| Net Change in Cash | 1.89M | -941.10K | -1.40M | -119.30K | -1.16M |